Cellular zinc deficiency has been shown to upregulate NF-κB activity in endothelial cells [85] and high concentrations of NF-κB have been found to be present in the smooth muscle cells of the atherosclerotic lesion [86]. The gene discussed is NFKB1; the disease is Zinc deficiency.